Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Kenneth Zahka, MD

216.445.5015

Kenneth Zahka, MD

Appointed: 2009

Kenneth Zahka, MD
Department: Pediatric Cardiology
Location: Cleveland Clinic Main Campus
Mail Code M41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.5015
DeskDesk:216.445.7146
WorkFax:216.445.3692
Kenneth Zahka, MD
Department: Pediatric Cardiology
Location: Strongsville Family Health Center
Mail Code M41
16761 S Park Center
Strongsville, OH 44136
WorkAppointment:216.445.5015
DeskDesk:216.445.7146
WorkFax:216.445.3692
Kenneth Zahka, MD
Department: Pediatric Cardiology
Location: Beachwood Family Health Center
Mail Code M41
26900 Cedar Road
Beachwood, OH 44122
WorkAppointment:216.445.5015
DeskDesk:216.445.7146
WorkFax:216.445.3692
Kenneth Zahka, MD
Department: Cardiovascular Medicine
Location: Cleveland Clinic Main Campus
Mail Code M41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.5015
DeskDesk:216.445.7146
WorkFax:216.445.3692
Kenneth Zahka, MD
Department: Pediatric Cardiology
Location: Avon Lake Family Health Center
Mail Code M41
450 Avon Belden Road
Avon Lake, OH 44012
WorkAppointment:440.695.4000
WorkFax:216.445.3692
Surgeon:
No
Treats:
Both Adults and Children & Adolescents

Biographical Sketch

Following residency in pediatrics and fellowship pediatric cardiology and a faculty position at Johns Hopkins, Dr Zahka moved to Cleveland as Director of Pediatric Cardiology at Rainbow Babies and Children's Hospital.  After nearly 20 years at Rainbow he joined the staff of the Cleveland Clinic Children's Hospital in July 2009.  He holds the academic rank of Professor of Pediatrics at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University School of Medicine. 

 

His clinical focus is genetic forms of cardiovascular disease including hypertrophic cardiomyopathy and connective tissue diseases.  His current clinical research centers on the understanding of the impact of the founder gene mutation of myosin binding protein C3 in the Old Order Amish.  His current education focus is curriculum development to facilitate cardiology fellowship training in cardiopulmonary exercise testing and physiology.

 

He has been dedicated to the enhancement and development of cardiovascular care abroad, working with cardiologists in the Middle East, Kenya, Armenia, Russia and Ecuador.   He has been recognized by Best Doctors in Cleveland from Cleveland Magazine and Best Doctors in America.  He is a consultant for the Food and Drug Administration and the genetic testing company, Familion.

Education & Fellowships

Fellowship - Johns Hopkins Hospital
Pediatric Cardiology
Baltimore, MD USA
1981
Residency - Johns Hopkins Hospital
Pediatrics
Baltimore, MD USA
1978
Internship - Johns Hopkins Hospital
Pediatrics
Baltimore, MD USA
1976
Medical School - Johns Hopkins University School of Medicine
Baltimore, MD USA
1975
Undergraduate - Boston University
Boston, MA USA
1971

Certifications

  • Pediatrics
  • Pediatrics- Pediatric Cardiology

Specialty Interests

Genetic cardiovascular disease: hypertrophic cardiomyopathy, Marfan Syndrome, Ehlers-Danlos Syndrome, familial aortic aneurysm, mitochondrial disease, cardiovascular sports medicine, exercise physiology and testing, adult congenital heart disease

Memberships

American Society of Echocardiography
American Academy of Pediatrics
American College of Cardiology
American Heart Association

Treatment & Services

  • Clinical Cardiology, Echocardiography, Cardiac Mri
  • Department of Pediatric Cardiology & CT Surgery
  • Echocardiography in Congenital Heart Disease
  • Fetal Echocardiogram
  • Hypertrophic Cardiomyopathy Center
  • Pediatric Cardiology
  • Pediatric Echocardiography

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/19/2014, Dr. Zahka has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English